BRCA1- and BRCA2-associated breast cancer is more sensitive to standard chemotherapy for metastatic disease in comparison with sporadic breast cancer.
M. Kriege,C. Seynaeve,H. Meyers-Heijboer,M. Collee,M. B. E. Menke-Pluymers,C. C. M. Bartels,A. van den Ouweland,B. van Geel,M. Hooning,C. T. M. Brekelmans,J. G. M. Klijn
